4//SEC Filing
REARDON WILLIAM S 4
Accession 0001179110-18-008940
CIK 0000861838other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 4:00 PM ET
Size
5.7 KB
Accession
0001179110-18-008940
Insider Transaction Report
Form 4
REARDON WILLIAM S
Director
Transactions
- Award
Stock Options
2018-06-20$1.53/sh+50,000$76,500→ 50,000 totalExercise: $1.53From: 2019-06-20Exp: 2028-06-20→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]These options were granted pursuant to the Company's director compensation on the date of the Company's 2018 annual meeting of stockholders at an exercise price to the closing price of the Company's common stock on the date of grant.
- [F2]These options will vest in full and become immediately exercisable on the first anniversary of the date of grant, subject to continued service as director, and are granted under the Company's 2013 Stock Incentive Plan, as amended.
Documents
Issuer
IDERA PHARMACEUTICALS, INC.
CIK 0000861838
Entity typeother
Related Parties
1- filerCIK 0001212646
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 4:00 PM ET
- Size
- 5.7 KB